New York, Jan 9, 2026, 06:19 EST — Premarket
China SXT Pharmaceuticals Inc shares ended Thursday down 37.5% at $1.25 after swinging between $1.21 and $6.98, with volume jumping to about 109.3 million shares, Yahoo Finance data showed. The day before, the stock closed at $2.00 on roughly 115,000 shares. (Yahoo Finance)
The China-based maker of traditional Chinese medicine products said it launched a “Strategic Artificial Intelligence (AI) Insights Initiative” to apply AI analytics to product planning, market intelligence and research decisions, and it plans offline AI-supported consultation stores across China. “Leveraging AI to gain insight into product trends and market dynamics is both a logical and necessary step,” co-chief executive officer Feng Zhou said. (GlobeNewswire)
The move matters now because SXTC is thinly traded and small news can get amplified, especially when it touches on a theme investors are already scanning for. Barchart data put first resistance — a level where selling often gathers — near $5.08, with the stock’s 52-week range at $0.95 to $7.84. (Barchart)
In extended trade after the close, the stock was quoted around $1.48, up about 18%, according to MarketWatch data. That would still leave it far below Thursday’s intraday high. (MarketWatch)
But China SXT did not lay out the cost of its AI work and store rollout, a timetable for opening the first locations, or how it expects to handle regulation and consumer trust around AI-guided health services. If volume drops back, the stock’s next move can turn sharply on a handful of orders.
Outside the company, traders also have a macro catalyst on deck: the U.S. Employment Situation report is due at 8:30 a.m. EST, a release that can swing risk appetite ahead of the cash open. (Bureau of Labor Statistics)
Next up is that 8:30 a.m. data and the first prints after 9:30 a.m., with traders watching whether Thursday’s surge in activity proves sticky or fades as fast as it arrived.
